Skip to main content
. 2021 Nov 9;302(2):410–418. doi: 10.1148/radiol.2021210826

Figure 6:

Kaplan-Meier curves stratified according to increased and decreased intratumoral myo-inositol normalized by contralateral creatine (mI/c-Cr) for participants with intratumoral mI/c-Cr greater than 0.38 at baseline (mean survival time, 288 days) compared with those with mI/c-Cr less than 0.38 (mean survival time, 160 days). The Wilcoxon rank-sum exact test demonstrated evidence of difference in survival rates within the two groups (P < .001).

Kaplan-Meier curves stratified according to increased and decreased intratumoral myo-inositol normalized by contralateral creatine (mI/c-Cr) for participants with intratumoral mI/c-Cr greater than 0.38 at baseline (mean survival time, 288 days) compared with those with mI/c-Cr less than 0.38 (mean survival time, 160 days). The Wilcoxon rank-sum exact test demonstrated evidence of difference in survival rates within the two groups (P < .001).